MetaCap

Champions Oncology Inc. Company Profile

NASDAQ: CSBRHealthcareBiotechnologyUSD

4.98+0.10 (+2.05%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Champions Oncology at a glance

Champions Oncology Inc. (NASDAQ: CSBR) is a Biotechnology company in the Healthcare sector headquartered in Hackensack, NJ. Champions Oncology is led by Mr. Robert Brainin and employs about 214 people. At a market capitalization of $69.3 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0000771856, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Champions Oncology do?

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Business description based on the company's public filings.

Company information

Legal name
Champions Oncology Inc.
Ticker
NASDAQ: CSBR
Industry
Biotechnology
CEO
Mr. Robert Brainin
Employees
214
Headquarters
One University Plaza, Hackensack, NJ, United States
Phone
201 808 8400
Market cap
$69.31M
SEC CIK
0000771856

Companies similar to Champions Oncology

CSBR peer companies
CompanyPrice% ChgMarket capCompare
TENXTenax Therapeutics Inc.1.86-2.62%$69.61Mvs CSBR
FBIOFortress Biotech Inc.2.09+2.45%$69.70Mvs CSBR
GANXGain Therapeutics Inc.1.62-3.29%$70.48Mvs CSBR
HRTXHeron Therapeutics Inc.0.3582-6.79%$68.01Mvs CSBR
CINGCingulate Inc.4.88+0.21%$70.96Mvs CSBR
MAIAMAIA Biotechnology Inc.1.15-2.54%$71.00Mvs CSBR
HYFTMindWalk Holdings Corp.1.43-4.67%$67.37Mvs CSBR
ONCYOncolytics Biotech Inc.0.5444-8.63%$71.38Mvs CSBR

Related